Jonathan A Ledermann: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Oza, Amit M, Cook, Adrian D, Pfisterer, Jacobus, Embleton, Andrew, Ledermann, Jonathan A, Pujade-Lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Park-Simon, Tjoung

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 406 KB

english, 2015

52

Herpes Simplex Virus Infection of Dendritic Cells: Balance among Activation, Inhibition, and Immunity

Pollara, Gabriele, Speidel, Katharina, Samady, Laila, Rajpopat, Mansi, McGrath, Yvonne, Ledermann, Jonathan, Coffin, Robert S., Katz, David R., Chain, Benjamin

Journal:

The Journal of Infectious Diseases

Year:

2003

Language:

english

File:

PDF, 661 KB

english, 2003

53

PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions

Ledermann, Jonathan A, El-Khouly, Fatima

Journal:

British Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 702 KB

english, 2015

54

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

Colombo, Nicoletta, Creutzberg, Carien, Amant, Frederic, Bosse, Tjalling, González-Martín, Antonio, Ledermann, Jonathan, Marth, Christian, Nout, Remi, Querleu, Denis, Mirza, Mansoor Raza, Sessa, Crist

Journal:

Radiotherapy and Oncology

Year:

2015

Language:

english

File:

PDF, 705 KB

english, 2015

55

Cost-Effectiveness of BRCA1 and BRCA2 Mutation Testing to Target PARP Inhibitor Use in Platinum-Sensitive Recurrent Ovarian Cancer

Secord, Angeles Alvarez, Barnett, Jason Cory, Ledermann, Jonathan A., Peterson, Bercedis L., Myers, Evan R., Havrilesky, Laura J.

Journal:

International Journal of Gynecological Cancer

Year:

2013

Language:

english

File:

PDF, 1.71 MB

english, 2013

56

Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer

Ledermann, Jonathan A.

Journal:

International Journal of Gynecological Cancer

Year:

2011

Language:

english

File:

PDF, 1004 KB

english, 2011

57

Do Cell-Cycle Phase–Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?

Kuku, Stephanie, Proctor, Ian, Loddo, Marco, Kadalayil, Latha, KhoshZaban, Mohammed, Ledermann, Jonathan, McCormack, Mary

Journal:

International Journal of Gynecological Cancer

Year:

2015

Language:

english

File:

PDF, 642 KB

english, 2015

58

2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer

Stuart, Gavin C.E., Kitchener, Henry, Bacon, Monica, duBois, Andreas, Friedlander, Michael, Ledermann, Jonathan, Marth, Christian, Thigpen, Tate, Trimble, Edward

Journal:

International Journal of Gynecological Cancer

Year:

2011

Language:

english

File:

PDF, 487 KB

english, 2011

59

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Drew, Yvette, Ledermann, Jonathan, Hall, Geoff, Rea, Daniel, Glasspool, Ros, Highley, Martin, Jayson, Gordon, Sludden, Julieann, Murray, James, Jamieson, David, Halford, Sarah, Acton, Gary, Backholer,

Journal:

British Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 526 KB

english, 2016

60

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Ledermann, Jonathan A, Embleton, Andrew C, Raja, Fharat, Perren, Timothy J, Jayson, Gordon C, Rustin, Gordon J S, Kaye, Stan B, Hirte, Hal, Eisenhauer, Elizabeth, Vaughan, Michelle, Friedlander, Micha

Journal:

Year:

2016

Language:

english

File:

PDF, 660 KB

english, 2016

61

Homologous recombination deficiency and ovarian cancer

Ledermann, Jonathan A., Drew, Yvette, Kristeleit, Rebecca S.

Journal:

European Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 1.09 MB

english, 2016

62

How Should We Manage Patients with “Platinum-Sensitive” Recurrent Ovarian Cancer?

Ledermann, Jonathan A., Wheeler, Sarah

Journal:

Cancer Investigation

Year:

2004

Language:

english

File:

PDF, 381 KB

english, 2004

63

Biology of lung cancer

Ledermann, Jonathan A., Souhami, Robert L.

Journal:

Current Opinion in Oncology

Year:

1993

File:

PDF, 769 KB

1993

64

Family History and Women With Ovarian Cancer

Lanceley, Anne, Eagle, Zara, Ogden, Gemma, Gessler, Sue, Razvi, Khalil, Ledermann, Jonathan A., Side, Lucy

Journal:

International Journal of Gynecological Cancer

Year:

2012

Language:

english

File:

PDF, 552 KB

english, 2012

65

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

Colombo, Nicoletta, Creutzberg, Carien, Amant, Frederic, Bosse, Tjalling, González-Martín, Antonio, Ledermann, Jonathan, Marth, Christian, Nout, Remi, Querleu, Denis, Mirza, Mansoor Raza, Sessa, Crist

Journal:

International Journal of Gynecological Cancer

Year:

2016

Language:

english

File:

PDF, 394 KB

english, 2016

66

Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer

Ledermann, Jonathan A., Marth, Christian, Carey, Mark S., Birrer, Michael, Bowtell, David D.L., Kaye, Stan, McNeish, Iain, Oza, Amit, Scambia, Giovanni, Rustin, Gordon, Stehman, Frederick B., Gershens

Journal:

International Journal of Gynecological Cancer

Year:

2011

Language:

english

File:

PDF, 1.48 MB

english, 2011

67

European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015

du Bois, Andreas, Reuss, Alexander, Pujade-Lauraine, Eric, Pignata, Sandro, Ledermann, Jonathan, Casado, Antonio, Sehouli, Jalid, Mirza, Mansoor, Colombo, Nicoletta, Marth, Christian, Witteveen, Els,

Journal:

International Journal of Gynecological Cancer

Year:

2015

Language:

english

File:

PDF, 71 KB

english, 2015

68

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessand

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 513 KB

english, 2016

69

Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective review

Marchetti, Claudia, Kristeleit, Rebecca, McCormack, Mary, Mould, Tim, Olaitan, Adeola, Widschwendter, Martin, MacDonald, Nicola, Ledermann, Jonathan A

Journal:

Gynecologic Oncology

Year:

2016

Language:

english

File:

PDF, 334 KB

english, 2016

70

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer

Ledermann, Jonathan A, Harter, Philipp, Gourley, Charlie, Friedlander, Michael, Vergote, Ignace, Rustin, Gordon, Scott, Clare, Meier, Werner, Shapira-Frommer, Ronnie, Safra, Tamar, Matei, Daniela, Fie

Journal:

British Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 263 KB

english, 2016

71

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Drew, Yvette, Ledermann, Jonathan, Hall, Geoff, Rea, Daniel, Glasspool, Ros, Highley, Martin, Jayson, Gordon, Sludden, Julieann, Murray, James, Jamieson, David, Halford, Sarah, Acton, Gary, Backholer,

Journal:

British Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 103 KB

english, 2016

72

The European Society for Medical Oncology (ESMO) Congress 2016: Highlights and summary of selected abstracts in gynecologic cancers

Miller, Rowan E., Ledermann, Jonathan A.

Journal:

Gynecologic Oncology

Year:

2017

Language:

english

File:

PDF, 236 KB

english, 2017

73

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease

Bangham, Madeleine, Goldstein, Robert, Walton, Henry, Ledermann, Jonathan A

Journal:

Gynecologic Oncology Reports

Year:

2016

Language:

english

File:

PDF, 520 KB

english, 2016

74

Targeted Therapies for Ovarian Cancer

Grunewald, Tami, Ledermann, Jonathan A.

Journal:

Best Practice & Research Clinical Obstetrics & Gynaecology

Year:

2016

Language:

english

File:

PDF, 357 KB

english, 2016

75

Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial

Stark, Dan P., Cook, Adrian, Brown, Julia M., Brundage, Michael D., Embleton, Andrew C., Kaplan, Richard S., Raja, Fharat A., Swart, Ann Marie W., Velikova, Galina, Qian, Wendi, Ledermann, Jonathan A.

Journal:

Year:

2017

Language:

english

File:

PDF, 363 KB

english, 2017

76

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mirza, Mansoor R., Monk, Bradley J., Herrstedt, Jørn, Oza, Amit M., Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A., Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E., Marth

Journal:

Obstetric and Gynecologic Survey

Year:

2017

Language:

english

File:

PDF, 90 KB

english, 2017

77

British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice

Fotopoulou, Christina, Hall, Marcia, Cruickshank, Derek, Gabra, Hani, Ganesan, Raji, Hughes, Cathy, Kehoe, Sean, Ledermann, Jonathan, Morrison, Jo, Naik, Raj, Rolland, Phil, Sundar, Sudha

Journal:

European Journal of Obstetrics & Gynecology and Reproductive Biology

Year:

2017

Language:

english

File:

PDF, 465 KB

english, 2017

78

Outcome of Patients With Advanced Ovarian Cancer Who Do Not Undergo Debulking Surgery

Marchetti, Claudia, Kristeleit, Rebecca, McCormack, Mary, Mould, Tim, Olaitan, Adeola, Widschwendter, Martin, MacDonald, Nicola, Ledermann, Jonathan A.

Journal:

Obstetric and Gynecologic Survey

Year:

2017

Language:

english

File:

PDF, 86 KB

english, 2017

79

Antiangiogenic Agents in Cancer Therapy

Ledermann, Jonathan A

Journal:

Journal of the Royal Society of Medicine

Year:

1999

Language:

english

File:

PDF, 196 KB

english, 1999

80

Ovarian Cancer Follow-up

Lanceley, Anne, Berzuini, Carlo, Burnell, Matthew, Gessler, Sue, Morris, Stephen, Ryan, Andy, Ledermann, Jonathan A., Jacobs, Ian

Journal:

International Journal of Gynecological Cancer

Year:

2017

Language:

english

File:

PDF, 316 KB

english, 2017

81

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Pujade-Lauraine, Eric, Ledermann, Jonathan A, Selle, Frédéric, Gebski, Val, Penson, Richard T, Oza, Amit M, Korach, Jacob, Huzarski, Tomasz, Poveda, Andrés, Pignata, Sandro, Friedlander, Michael, Colo

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 586 KB

english, 2017

82

Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy

Milani, Andrea, Kristeleit, Rebecca, McCormack, Mary, Raja, Fharat, Luvero, Daniela, Widschwendter, Martin, MacDonald, Nicola, Mould, Tim, Olatain, Adeola, Hackshaw, Allan, Ledermann, Jonathan A

Journal:

Year:

2017

Language:

english

File:

PDF, 993 KB

english, 2017

83

Primary Chemotherapy

Ledermann, Jonathan A.

Journal:

International Journal of Gynecological Cancer

Year:

2010

Language:

english

File:

PDF, 501 KB

english, 2010

84

Long term radiological features of radiation-induced lung damage

Veiga, Catarina, Landau, David, McClelland, Jamie R., Ledermann, Jonathan A., Hawkes, David, Janes, Sam M., Devaraj, Anand

Journal:

Radiotherapy and Oncology

Year:

2017

Language:

english

File:

PDF, 1.66 MB

english, 2017

85

European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Pharmaceutical Companies

Vergote, Ignace, Pujade-Lauraine, Eric, Pignata, Sandro, Kristensen, Gunnar B., Ledermann, Jonathan, Casado, Antonio, Sehouli, Jalid, Mirza, Mansoor, Fossati, Roldano, Marth, Christian, Creutzberg, Ca

Journal:

International Journal of Gynecological Cancer

Year:

2010

Language:

english

File:

PDF, 504 KB

english, 2010

86

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

Ruers, Theo, Van Coevorden, Frits, Punt, Cornelis J. A., Pierie, Jean-Pierre E. N., Borel-Rinkes, Inne, Ledermann, Jonathan A., Poston, Graeme, Bechstein, Wolf, Lentz, Marie-Ange, Mauer, Murielle, Fol

Journal:

JNCI Journal of the National Cancer Institute

Year:

2017

Language:

english

File:

PDF, 810 KB

english, 2017

87

Mainstreamed genetic testing for women with ovarian cancer: first-year experience

Rahman, Belinda, Lanceley, Anne, Kristeleit, Rebecca S, Ledermann, Jonathan A, Lockley, Michelle, McCormack, Mary, Mould, Tim, Side, Lucy

Journal:

Journal of Medical Genetics

Year:

2018

Language:

english

File:

PDF, 167 KB

english, 2018

88

First-line treatment of ovarian cancer: questions and controversies to address

Ledermann, Jonathan A.

Journal:

Therapeutic Advances in Medical Oncology

Year:

2018

Language:

english

File:

PDF, 92 KB

english, 2018

89

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference

Jang, Ji Yon Agnes, Yanaihara, Nozomu, Pujade-Lauraine, Eric, Mikami, Yoshiki, Oda, Katsutoshi, Bookman, Michael, Ledermann, Jonathan, Shimada, Muneaki, Kiyokawa, Takako, Kim, Byoung-Gie, Matsumura, N

Journal:

Journal of Gynecologic Oncology

Year:

2017

Language:

english

File:

PDF, 533 KB

english, 2017

90

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

González Martín, Antonio, Oza, Amit M., Embleton, Andrew C., Pfisterer, Jacobus, Ledermann, Jonathan A., Pujade-Lauraine, Eric, Kristensen, Gunnar, Bertrand, Monique A., Beale, Philip, Cervantes, Andr

Journal:

Gynecologic Oncology

Year:

2018

Language:

english

File:

PDF, 962 KB

english, 2018

91

Update on first-line treatment of advanced ovarian carcinoma

Ledermann, Jonathan, Kemp,

Journal:

International Journal of Women's Health

Year:

2013

Language:

english

File:

PDF, 218 KB

english, 2013

92

Effects of Acceptance and Commitment Therapy on Impulsive Decision-Making

Morrison, Kate L., Smith, Brooke M., Ong, Clarissa W., Lee, Eric B., Friedel, Jonathan E., Odum, Amy, Madden, Gregory J., Ledermann, Thomas, Rung, Jillian, Twohig, Michael P.

Journal:

Behavior Modification

Year:

2019

File:

PDF, 259 KB

2019

93

Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer?

Ledermann, Jonathan A.

Journal:

Gynecologic Oncology

Year:

2019

Language:

english

File:

PDF, 239 KB

english, 2019

94

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer

Ledermann, Jonathan A., Pujade-Lauraine, Eric

Journal:

Therapeutic Advances in Medical Oncology

Year:

2019

Language:

english

File:

PDF, 981 KB

english, 2019

95

Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application

Embleton-Thirsk, Andrew, Deane, Elizabeth, Townsend, Stephen, Farrelly, Laura, Popoola, Babasola, Parker, Judith, Rustin, Gordon, Sydes, Matthew, Parmar, Mahesh, Ledermann, Jonathan, Kaplan, Richard

Journal:

Clinical Trials

Year:

2019

Language:

english

File:

PDF, 827 KB

english, 2019

96

Olaparib maintenance for first-line treatment of ovarian cancer: will SOLO1 reset the standard of care?

Miller, Rowan E, Crusz, Shanthini M, Ledermann, Jonathan A

Journal:

Future Oncology

Year:

2019

Language:

english

File:

PDF, 1.69 MB

english, 2019

97

Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial

Matulonis, Ursula A., Walder, Lydia, Nøttrup, Trine J., Bessette, Paul, Mahner, Sven, Gil-Martin, Marta, Kalbacher, Elsa, Ledermann, Jonathan A., Wenham, Robert M., Woie, Kathrine, Lau, Susie, Marmé,

Journal:

Journal of Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 742 KB

english, 2019

98

Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial

Matulonis, Ursula A., Walder, Lydia, Nøttrup, Trine J., Bessette, Paul, Mahner, Sven, Gil-Martin, Marta, Kalbacher, Elsa, Ledermann, Jonathan A., Wenham, Robert M., Woie, Kathrine, Lau, Susie, Marmé,

Journal:

Journal of Clinical Oncology

Year:

2019

File:

PDF, 742 KB

2019

99

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process

McLeavy, Laura, Rahman, Belinda, Kristeleit, Rebecca, Ledermann, Jonathan, Lockley, Michelle, McCormack, Mary, Mould, Tim, Side, Lucy, Lanceley, Anne

Journal:

International Journal of Gynecological Cancer

Year:

2019

Language:

english

File:

PDF, 383 KB

english, 2019

100

Mainstreamed genetic testing in ovarian cancer: patient experience of the testing process

McLeavy, Laura, Rahman, Belinda, Kristeleit, Rebecca, Ledermann, Jonathan, Lockley, Michelle, McCormack, Mary, Mould, Tim, Side, Lucy, Lanceley, Anne

Journal:

International Journal of Gynecological Cancer

Year:

2019

File:

PDF, 383 KB

2019